Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > 50$ in 6 months

<< Previous

Bullboard Posts

Next >>

Comment by WakeUPPon Feb 09, 2022 11:08am

80 Views

Post# 34412505

RE:50$ in 6 months

ah hhahahaahahahhaaha

skylight is calling people stupid

roflmao

there are a few stupid people here skylight, but none close to as stupid as the crazy posts you make.. WHEN are "your drs" gonna buy???????? hahahahahaha

EVERY SINGLE thing you have every posted here has been WRONG

YOU are taken in by lex spending like crazy on STOCK PROMOTION

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale